Clinical Trial Update: Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD. [NA]

View source ↗

Summary

Clinical trial update on the efficacy and safety of task-specific, biomarker-driven, HD-ctACS in treatment-resistant depression, sponsored by Ruijin Hospital, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• HD-ctACS inTRD

Snippet

Sponsor: Ruijin Hospital | Conditions: Major Depression | NA | Status: ACTIVE_NOT_RECRUITING